News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
886,363 Results
Type
Article (88991)
Company Profile (555)
Press Release (796798)
Multimedia
Podcasts (249)
Webinars (36)
Section
Business (267095)
Career Advice (4167)
Deals (40038)
Drug Delivery (182)
Drug Development (91805)
Employer Resources (208)
FDA (18613)
Job Trends (17500)
News (398947)
Policy (40027)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (4)
2027 Genetown Standard (7)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (7)
Academia (3067)
Academic (2)
Accelerated approval (60)
ADA (50)
Adcomms (43)
Allergies (211)
Alliances (56991)
ALS (246)
Alzheimer's disease (2050)
Antibody-drug conjugate (ADC) (602)
Approvals (19021)
Artificial intelligence (940)
ASCO (345)
Autoimmune disease (390)
Automation (71)
Bankruptcy (409)
Best Places to Work (12635)
BIO (80)
BIOSECURE Act (23)
Biosimilars (264)
Biotechnology (336)
Bladder cancer (219)
Brain cancer (87)
Breast cancer (870)
Cancer (6890)
Cardiovascular disease (583)
Career advice (3604)
Career pathing (55)
CAR-T (400)
CDC (77)
Celiac Disease (3)
Cell therapy (1118)
Cervical cancer (60)
Clinical research (79509)
Collaboration (2504)
Commercialization (1)
Company closure (8)
Compensation (1618)
Complete response letters (118)
COVID-19 (3047)
CRISPR (130)
C-suite (1390)
Cystic fibrosis (170)
Data (9131)
Decentralized trials (3)
Denatured (95)
Depression (207)
Dermatology (109)
Diabetes (737)
Diagnostics (7680)
Digital health (75)
Diversity (14)
Diversity, equity & inclusion (49)
Drug discovery (475)
Drug pricing (248)
Drug shortages (39)
Duchenne muscular dystrophy (338)
Earnings (102672)
Editorial (81)
Employer branding (25)
Employer resources (177)
Events (139121)
Executive appointments (1246)
FDA (22942)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (23)
Frontotemporal dementia (37)
Funding (2046)
Gene editing (285)
Generative AI (95)
Gene therapy (880)
GLP-1 (1306)
Government (5571)
Grass and pollen (8)
Guidances (427)
Healthcare (21280)
Hematology (198)
HIV (106)
Huntington's disease (73)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (122)
Immunology and inflammation (370)
Immuno-oncology (124)
Indications (230)
Infectious disease (3462)
Inflammatory bowel disease (248)
Inflation Reduction Act (17)
Influenza (156)
Intellectual property (341)
Interviews (823)
IPO (18022)
IRA (61)
Job creations (5209)
Job search strategy (2872)
JPM (73)
Kidney cancer (25)
Labor market (129)
Layoffs (698)
Leadership (56)
Legal (10172)
Liver cancer (111)
Longevity (38)
Lung cancer (911)
Lymphoma (495)
Machine learning (70)
Management (68)
Manufacturing (1326)
Marketing (8)
MASH (233)
Medical affairs (1)
Medical device (15330)
Medtech (15538)
Mergers & acquisitions (23397)
Metabolic disorders (1896)
mRNA (283)
Multiple sclerosis (216)
NASH (24)
Neurodegenerative disease (549)
Neuropsychiatric disorders (133)
Neuroscience (3896)
Neurotech (2)
NextGen: Class of 2026 (7717)
Non-profit (5150)
Now hiring (84)
Obesity (897)
Opinion (385)
Ovarian cancer (257)
Pain (298)
Pancreatic cancer (378)
Parkinson's disease (433)
Partnered (43)
Patents (701)
Patient recruitment (851)
Peanut (72)
People (68267)
Pharmaceutical (81)
Pharmacy benefit managers (38)
Phase 1 (24561)
Phase 2 (34538)
Phase 3 (25966)
Pipeline (10628)
Policy (408)
Postmarket research (3561)
Preclinical (11016)
Press Release (72)
Prostate cancer (363)
Psychedelics (81)
Radiopharmaceuticals (385)
Rare diseases (1357)
Real estate (7467)
Recruiting (82)
Regulatory (30790)
Reports (78)
Research institute (2781)
Resumes & cover letters (655)
Rett syndrome (47)
RNA editing (31)
RSV (100)
Schizophrenia (199)
Series A (350)
Series B (253)
Service/supplier (15)
Sickle cell disease (135)
Special edition (33)
Spinal muscular atrophy (193)
Sponsored (55)
Startups (4378)
State (2)
Stomach cancer (21)
Supply chain (152)
Tariffs (104)
The Weekly (151)
Vaccines (1341)
Venture capital (143)
Weight loss (608)
Women's health (149)
Worklife (25)
Date
Today (129)
Last 7 days (506)
Last 30 days (2193)
Last 365 days (33405)
2026 (18989)
2025 (33214)
2024 (37864)
2023 (42564)
2022 (53928)
2021 (58720)
2020 (57663)
2019 (51334)
2018 (39119)
2017 (37188)
2016 (38329)
2015 (44432)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1299)
Alabama (103)
Alaska (7)
Arizona (418)
Arkansas (16)
Asia (52506)
Australia (9231)
California (14864)
Canada (4174)
China (1685)
Colorado (639)
Connecticut (653)
Delaware (459)
Europe (121072)
Florida (2237)
Georgia (485)
Hawaii (4)
Idaho (70)
Illinois (1303)
India (113)
Indiana (684)
Iowa (25)
Japan (637)
Kansas (145)
Kentucky (58)
Louisiana (64)
Maine (92)
Maryland (1783)
Massachusetts (10859)
Michigan (430)
Minnesota (828)
Mississippi (7)
Missouri (169)
Montana (37)
Nebraska (31)
Nevada (160)
New Hampshire (92)
New Jersey (3934)
New Mexico (36)
New York (3922)
North Carolina (1964)
North Dakota (11)
Northern California (7432)
Ohio (465)
Oklahoma (29)
Oregon (46)
Pennsylvania (2907)
Puerto Rico (33)
Rhode Island (53)
South America (1671)
South Carolina (92)
South Dakota (2)
Southern California (5873)
Tennessee (243)
Texas (2413)
United States (53053)
Utah (447)
Vermont (2)
Virginia (370)
Washington D.C. (88)
Washington State (1208)
West Virginia (4)
Wisconsin (163)
Wyoming (2)
There are 886,363 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Podcast
Q2 earnings underway, FDA’s CRL kerfuffle, IPOs full speed ahead in H2
Second quarter earnings continue to roll with Novartis and Roche reporting this week; Eli Lilly’s AtaiBeckley buy for up to $3.8 billion offers clear “validation” for the fledgling psychedelics space; more drama unfolds at FDA as the agency goes back and forth on its policy of publishing complete response letters in real-time; and IPO fever continues.
July 22, 2026
·
1 min read
·
Jef Akst
Press Releases
Healx Announces First Patient Dosed in Phase 1/2 Trial to Evaluate the Effect of HLX-4310 on Metastatic Recurrence and Progression in Sarcomas with a Focus on Osteosarcoma
July 22, 2026
·
5 min read
Press Releases
Ipsen completes acquisition of Memo Therapeutics AG, adding first-in-class asset to Ipsen’s Rare Disease pipeline
July 22, 2026
·
7 min read
Press Releases
Vivoryon Therapeutics N.V. to Report H1 2026 Financial Results and Business Updates on August 6, 2026; Annual General Meeting Planned for End of September 2026
July 22, 2026
·
3 min read
Press Releases
Dyne Therapeutics Announces Pricing of Upsized $375 Million Public Offering of Common Stock
July 22, 2026
·
5 min read
Press Releases
BIO Asia-Taiwan 2026 Unites 60 Countries, Showcasing Taiwan as a Global Biotech Innovation Partner
July 22, 2026
·
4 min read
Press Releases
D&D Pharmatech Announces The Lancet Gastroenterology & Hepatology Publication of Phase 2 Data Demonstrating Rapid, Weight-Independent Activity of Zabopegdutide (DD01) in MASLD/MASH
July 22, 2026
·
6 min read
Press Releases
Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance
July 22, 2026
·
5 min read
Press Releases
N-Zyme Biomedical Closes US$4.6 Million Series A Financing to Advance Clinical Development
July 22, 2026
·
4 min read
Press Releases
Gilead Sciences to Release Second Quarter 2026 Financial Results on Tuesday, August 4, 2026
July 22, 2026
·
1 min read
1 of 88,637
Next
